Literature DB >> 11770988

Opsonic capacity of foal serum for the two neonatal pathogens Escherichia coli and Actinobacillus equuli.

G Gröndahl1, S Sternberg, M Jensen-Waern, A Johannisson.   

Abstract

Two of the most commonly isolated foal pathogens are Escherichia coli and Actinobacillus equuli. The hypothesis tested in this study was that young foals carry a lower opsonic capacity for these bacteria compared to adult horses. A flow-cytometric method for the phagocytosis of these by equine neutrophils was established. The opsonic capacity of serum from healthy foals from birth to age 6 weeks was evaluated and related to the concentrations of IgGa and IgGb. Phagocytosis of yeast was used as a control. Serum was required for phagocytosis, with higher concentrations for E. coli than for A. equuli. Ingestion of colostrum led to a significantly higher serum opsonic capacity. After that, there was no consistent age-related trend for opsonic capacity for the different microbes. Foal serum showed similar or higher opsonisation of E. coli and A. equuli compared to serum from mature individuals. During the studied period, the predominance among IgG subisotypes switched from IgGb to IgGa. Although the overall correlation between concentrations of IgG subisotypes and serum opsonic capacity was poor, sera with IgGb levels below 1.9 mg/ml induced lower opsonisation of E. coli and yeast, but not of A. equuli. Complement activation was important for opsonisation of all tested microbes. The results of this study are significant to the understanding of a key immunological facet in the pathophysiology of equine neonatal septicaemia in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11770988     DOI: 10.2746/042516401776249381

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  5 in total

1.  Identification of pulmonary T-lymphocyte and serum antibody isotype responses associated with protection against Rhodococcus equi.

Authors:  A Marianela Lopez; Melissa T Hines; Guy H Palmer; Debra C Alperin; Stephen A Hines
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

2.  The effectiveness of anti-R. equi hyperimmune plasma against R. equi challenge in thoroughbred Arabian foals of mares vaccinated with R. equi vaccine.

Authors:  Osman Erganis; Zafer Sayin; Hasan Huseyin Hadimli; Asli Sakmanoglu; Yasemin Pinarkara; Ozgur Ozdemir; Mehmet Maden
Journal:  ScientificWorldJournal       Date:  2014-04-03

3.  In vitro evaluation of complement deposition and opsonophagocytic killing of Rhodococcus equi mediated by poly-N-acetyl glucosamine hyperimmune plasma compared to commercial plasma products.

Authors:  Chelsea N Folmar; Colette Cywes-Bentley; Angela I Bordin; Joana N Rocha; Jocelyne M Bray; Susanne K Kahn; Amanda E Schuckert; Gerald B Pier; Noah D Cohen
Journal:  J Vet Intern Med       Date:  2019-04-29       Impact factor: 3.333

4.  The different effector function capabilities of the seven equine IgG subclasses have implications for vaccine strategies.

Authors:  Melanie J Lewis; Bettina Wagner; Jenny M Woof
Journal:  Mol Immunol       Date:  2007-07-31       Impact factor: 4.407

5.  Serum Antibody Activity against Poly-N-Acetyl Glucosamine (PNAG), but Not PNAG Vaccination Status, Is Associated with Protecting Newborn Foals against Intrabronchial Infection with Rhodococcus equi.

Authors:  Noah D Cohen; Susanne K Kahn; Colette Cywes-Bentley; Sophia Ramirez-Cortez; Amanda E Schuckert; Mariana Vinacur; Angela I Bordin; Gerald B Pier
Journal:  Microbiol Spectr       Date:  2021-07-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.